Oxaliplatin-based Therapy

Oxaliplatin-Based Therapy is a chemotherapy regimen in which oxaliplatin serves as the foundational cytotoxic agent, distinguishing it from other gastrointestinal cancer pharmacotherapies by its platinum-derived mechanism of action that induces DNA cross-linking and apoptosis in neoplastic cells.

4.1K

Publications

283.4K

Citations

24.1K

Authors

4.3K

Institutions

Publications per year

2017–2026

1.3K

Authors

24.1K

  1. TA
    Thierry André

    Sorbonne Université, France

    77 publications · 20.2K citations

    46

    h-index

  2. AD
    Aimery de Gramont

    Sorbonne Université, France

    67 publications · 21.8K citations

    42

    h-index

  3. JT
    Josep Tabernero

    Vall d'Hebron Hospital Universitari, Spain

    65 publications · 17.2K citations

    38

    h-index

  4. CL
    Christophe Louvet

    Sorbonne Université, France

    56 publications · 17K citations

    36

    h-index

  5. EV
    Eric Van Cutsem

    KU Leuven, Belgium

    59 publications · 7.9K citations

    36

    h-index

1–5 of 24.1K

Venues

  1. Journal of Clinical Oncology

    482 publications · 79.5K citations

    131

    h-index

  2. Annals of Oncology

    195 publications · 16.7K citations

    68

    h-index

  3. British Journal of Cancer

    BJC · 119 publications · 7.7K citations

    51

    h-index

  4. PubMed

    Repository · 216 publications · 8.8K citations

    46

    h-index

  5. European Journal of Cancer

    80 publications · 5.1K citations

    38

    h-index

1–5